What to Know About BCG Treatments for Bladder Cancer with Dr. Ashish Kamat

In Episode 37 of "Bladder Cancer Matters," host Rick Bangs talks with two-time return guest Dr. Ashish Kamat. Dr. Kamat is a professor of urology and director of bladder cancer research at MD Anderson Cancer Center in Houston, Texas. He's also a member of the Bladder Cancer Advocacy Network's Scientific Advisory Board. Rick and Dr. Kamat talk about what is on the mind of many bladder cancer patients: what to expect before, during and after BCG treatments for non muscle-invasive bladder cancer. They chat about:   How BCG treatments work What patients can expect before treatment – is there any sort of prep required? What the treatment itself is like What patients and expect following a treatment, including side effects The "right" number of treatments, given that some patients are receiving fewer treatments because of COVID or the shortage Dr. Kamat's prior two Bladder Cancer Matters podcast episodes include:   Episode 1, What's Up with Bladder Cancer and BCG, with Dr. Ashish Kamat Episode 4, The Slippery Slope of Bladder Cancer, Staging and Radical Cystectomies with Dr. Ashish Kamat Disclaimer: The views and opinions expressed in this podcast are those of the speakers and guests and do not necessarily reflect the views or positions of the Bladder Cancer Advocacy Network. Never miss an episode of Bladder Cancer Matters by subscribing in your favorite podcasting platform.    

There are no comments yet.

Please log in to write the first comment.